Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01837680 · ClinicalTrials.gov registry record · NA
Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy
A NA study, sponsored by St. Luke's-Roosevelt Hospital Center.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT01837680 is a NA study that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 105 participants.
The verdict
NCT01837680, a NA study, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
The aim of this study is to compare glycemic control in pregnant women treated with insulin Detemir and pregnant women treated with NPH insulin. These women are diagnosed with gestational diabetes (GDM) in the current pregnancy or have a preexisting diagnosis of type 2 diabetes (T2DM) at the onset of pregnancy. Our hypothesis is that there is no difference between these two treatment modalities in terms of glycemic control in diabetes.
Interventions
- DRUG Insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01837680
The ClinicalTrials.gov registry entry for NCT01837680 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's-Roosevelt Hospital Center, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Insulin is the first listed.
NCT01837680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01837680 about?
NCT01837680 is a clinical study titled "Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy". The aim of this study is to compare glycemic control in pregnant women treated with insulin Detemir and pregnant women treated with NPH insulin. These women are diagnosed with gestational diabetes (GDM) in the current pregnancy or have a preexisting diagnosis of type 2 diabetes (T2DM) at the onset o...
What is the current status of trial NCT01837680?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2013-03. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01837680?
The interventions under investigation include: Insulin (DRUG).
Who is sponsoring clinical trial NCT01837680?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.